...
search icon
gnlx-img

Genelux Corporation Common Stock Share Price

GNLX
NAQ
$2.49
+$0.07
(2.89%)
1D
Industry: Biotechnology Sector: Health Care

Genelux Corporation Common Stock Analyst Forecast

Genelux Corporation Common Stock Share Price Chart

Genelux Corporation Common Stock Key Stock Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$108.22M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
210.35K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
0.18
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$1.99 L
$8.54 H
$2.49

About Genelux Corporation Common Stock, Common Stock

Genelux Corporation, a clinical-stage biopharmaceutical company, focuses on developing oncolytic viral immunotherapies for patients suffering from aggressive and/or difficult-to-treat solid tumor types. Its lead product candidate is Olvi-Vec, a proprietary modified strain of the vaccinia virus indicated for the treatment of ovarian cancer and non-small cell lung cancer, as well as for liquid or solid tumors, appendiceal, colorectal and gastric cancers, other gynecologic malignancies, and peritoneal mesothelioma. The company has a licensing agreement with Newsoara BioPharma Co. Ltd. to research, develop, commercialize or exploit Olvi-Vec in China, including Mainland China, Taiwan, Hong Kong, and Macau, for human diagnostic, prophylactic, and therapeutic uses. Genelux Corporation was incorporated in 2001 and is headquartered in Westlake Village, California. more

Industry: BiotechnologySector: Health Care

Genelux Corporation Common Stock Stock Returns

Time FrameGNLXSectorS&P500
1-Week Return5.96%0.91%2.13%
1-Month Return-6.04%-0.72%-0.47%
3-Month Return-58.01%2.24%1.29%
6-Month Return-21.94%19.1%7.71%
1-Year Return-55.54%7.15%14.7%
3-Year Return-59.11%16.96%67.75%
5-Year Return-59.51%33.23%76.25%

Genelux Corporation Common Stock Financials

Dec '20Dec '21Dec '22Dec '23Dec '245YR TREND
Total Revenue--11.07M170.00K8.00K[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":1.54,"profit":true},{"date":"2024-12-31","value":0.07,"profit":true}]
Cost of Revenue658.00K895.00K968.00K1.02M903.00K[{"date":"2020-12-31","value":64.64,"profit":true},{"date":"2021-12-31","value":87.92,"profit":true},{"date":"2022-12-31","value":95.09,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":88.7,"profit":true}]
Gross Profit(658.00K)(895.00K)10.10M(848.00K)(895.00K)[{"date":"2020-12-31","value":-6.51,"profit":false},{"date":"2021-12-31","value":-8.86,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-8.4,"profit":false},{"date":"2024-12-31","value":-8.86,"profit":false}]
Gross Margin--91.25%(498.82%)(11187.50%)[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-546.63,"profit":false},{"date":"2024-12-31","value":-12259.73,"profit":false}]
Operating Expenses11.76M13.72M13.11M23.32M30.80M[{"date":"2020-12-31","value":38.19,"profit":true},{"date":"2021-12-31","value":44.54,"profit":true},{"date":"2022-12-31","value":42.57,"profit":true},{"date":"2023-12-31","value":75.7,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Operating Income(12.42M)(14.61M)(3.01M)(24.16M)(31.70M)[{"date":"2020-12-31","value":-1242200000,"profit":false},{"date":"2021-12-31","value":-1461300000,"profit":false},{"date":"2022-12-31","value":-301300000,"profit":false},{"date":"2023-12-31","value":-2416500000,"profit":false},{"date":"2024-12-31","value":-3169600000,"profit":false}]
Total Non-Operating Income/Expense(2.44M)(3.58M)(2.50M)(8.50M)3.28M[{"date":"2020-12-31","value":-74.36,"profit":false},{"date":"2021-12-31","value":-109.01,"profit":false},{"date":"2022-12-31","value":-76.19,"profit":false},{"date":"2023-12-31","value":-258.74,"profit":false},{"date":"2024-12-31","value":100,"profit":true}]
Pre-Tax Income(13.64M)(16.38M)(4.11M)(28.30M)(29.87M)[{"date":"2020-12-31","value":-1364300000,"profit":false},{"date":"2021-12-31","value":-1637800000,"profit":false},{"date":"2022-12-31","value":-410700000,"profit":false},{"date":"2023-12-31","value":-2829700000,"profit":false},{"date":"2024-12-31","value":-2986900000,"profit":false}]
Income Taxes1.22M1.42M1.10M850.11K-[{"date":"2020-12-31","value":86.17,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":77.63,"profit":true},{"date":"2023-12-31","value":59.99,"profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Income After Taxes(14.86M)(17.80M)(5.21M)(29.15M)-[{"date":"2020-12-31","value":-1486400000,"profit":false},{"date":"2021-12-31","value":-1779500000,"profit":false},{"date":"2022-12-31","value":-520700000,"profit":false},{"date":"2023-12-31","value":-2914710500,"profit":false},{"date":"2024-12-31","value":"-","profit":true}]
Income From Continuous Operations(13.64M)(16.38M)(5.21M)(25.02M)(29.87M)[{"date":"2020-12-31","value":-1364300000,"profit":false},{"date":"2021-12-31","value":-1637800000,"profit":false},{"date":"2022-12-31","value":-520700000,"profit":false},{"date":"2023-12-31","value":-2502500000,"profit":false},{"date":"2024-12-31","value":-2986900000,"profit":false}]
Income From Discontinued Operations-----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Net Income(14.86M)(17.80M)(5.21M)(28.30M)(29.87M)[{"date":"2020-12-31","value":-1486400000,"profit":false},{"date":"2021-12-31","value":-1779500000,"profit":false},{"date":"2022-12-31","value":-520700000,"profit":false},{"date":"2023-12-31","value":-2829700000,"profit":false},{"date":"2024-12-31","value":-2986900000,"profit":false}]
EPS (Diluted)--(0.40)(1.21)(0.95)[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":-40,"profit":false},{"date":"2023-12-31","value":-121,"profit":false},{"date":"2024-12-31","value":-95,"profit":false}]

Genelux Corporation Common Stock Ratios

Genelux Corporation Common Stock Liquidity Ratios

These ratios help you determine the liquidity of the company. Higher is better.

GNLX
Cash Ratio 4.08
Current Ratio 4.20

Genelux Corporation Common Stock Asset Efficiency Ratios

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

GNLX
ROA (LTM) -64.27%
ROE (LTM) -123.35%

Genelux Corporation Common Stock Liability Ratios

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

GNLX
Debt Ratio Lower is generally better. Negative is bad. 0.26
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.74

Genelux Corporation Common Stock Valuation Ratios

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

GNLX
Trailing PE NM
Forward PE NM
P/S (TTM) 12362.41
P/B 5.83
Price/FCF NM
EV/R 6302.51
EV/Ebitda NM

FAQs

What is Genelux Corporation Common Stock share price today?

Genelux Corporation Common Stock (GNLX) share price today is $2.49

Can Indians buy Genelux Corporation Common Stock shares?

Yes, Indians can buy shares of Genelux Corporation Common Stock (GNLX) on Vested. To buy

from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in GNLX stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Genelux Corporation Common Stock be purchased?

Yes, you can purchase fractional shares of Genelux Corporation Common Stock (GNLX) via the Vested app. You can start investing in Genelux Corporation Common Stock (GNLX) with a minimum investment of $1.

How to invest in Genelux Corporation Common Stock shares from India?

You can invest in shares of Genelux Corporation Common Stock (GNLX) via Vested in three simple steps:

  • Click on Sign Up or Invest in GNLX stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Genelux Corporation Common Stock shares
What is Genelux Corporation Common Stock 52-week high and low stock price?

The 52-week high price of Genelux Corporation Common Stock (GNLX) is $8.54. The 52-week low price of Genelux Corporation Common Stock (GNLX) is $1.99.

What is Genelux Corporation Common Stock price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Genelux Corporation Common Stock (GNLX) is

What is Genelux Corporation Common Stock price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Genelux Corporation Common Stock (GNLX) is 5.83

What is Genelux Corporation Common Stock dividend yield?

The dividend yield of Genelux Corporation Common Stock (GNLX) is 0.00%

What is the Market Cap of Genelux Corporation Common Stock?

The market capitalization of Genelux Corporation Common Stock (GNLX) is $108.22M

What is Genelux Corporation Common Stock's stock symbol?

The stock symbol (or ticker) of Genelux Corporation Common Stock is GNLX

How Can Investors Use Genelux Corporation Common Stock Share Price Data for Long-Term Investment Decisions?

Consider the share price of Genelux Corporation Common Stock as a long-term story and not a daily point list. The price represents a movement of the stock in both good and bad times when looked at over many years. This assists the investors to know whether Genelux Corporation Common Stock has succeeded to expand steadily and overcome market declines. With this price movement observed and the way the business is progressing, it is easier to make a decision whether the stock is worth having in the long term or not.

How does USD - INR currency movement impact returns from Genelux Corporation Common Stock shares for Indian investors?

When investing in Genelux Corporation Common Stock shares, you are not based in India then your investment is not just based on the stock price. It is also determined by the currency movement of the dollar in relation to the rupee. When you have an appreciation of the Genelux Corporation Common Stock stock and the dollar appreciation is also the same, you gain more in terms of rupees. When the rupee appreciated, it will lower your profits. This currency flow is a silent cause of great contribution to your ultimate returns over many years.

How should investors compare Genelux Corporation Common Stock share price with other stocks in the same sector?

Rather than merely checking the share price of Genelux Corporation Common Stock and comparing it with that of other stocks in the same sector, one can check how robust the business is. Investors tend to compare such aspects as profits, cash generation, and the stability of the revenues of the company. This means that Genelux Corporation Common Stock stock in most cases does not react in the same manner as other companies in the sector due to its brand and services revenue.

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top